These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience. Angelini A; Andersen CB; Bartoloni G; Black F; Bishop P; Doran H; Fedrigo M; Fries JW; Goddard M; Goebel H; Neil D; Leone O; Marzullo A; Ortmann M; Paraf F; Rotman S; Turhan N; Bruneval P; Frigo AC; Grigoletto F; Gasparetto A; Mencarelli R; Thiene G; Burke M J Heart Lung Transplant; 2011 Nov; 30(11):1214-20. PubMed ID: 21816625 [TBL] [Abstract][Full Text] [Related]
28. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis. Hammond MEH; Revelo MP; Miller DV; Snow GL; Budge D; Stehlik J; Molina KM; Selzman CH; Drakos SG; Rami A A; Nativi-Nicolau JN; Reid BB; Kfoury AG J Heart Lung Transplant; 2016 Mar; 35(3):320-325. PubMed ID: 26970471 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP. Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500 [TBL] [Abstract][Full Text] [Related]
30. Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection. Lin CM; Plenter RJ; Coulombe M; Gill RG Am J Transplant; 2016 Nov; 16(11):3121-3130. PubMed ID: 27163757 [TBL] [Abstract][Full Text] [Related]
31. Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantation. Yerly P; Rotman S; Nobile A; Aubert V; Tozzi P; Yarol N; Vogt P; Hullin R; Pascual M Transplantation; 2015 Mar; 99(3):586-93. PubMed ID: 24983305 [TBL] [Abstract][Full Text] [Related]
32. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft. Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561 [TBL] [Abstract][Full Text] [Related]
33. Ultrastructural changes in pulmonary allografts with antibody-mediated rejection. Alexander MP; Bentall A; Aleff PCA; Gandhi MJ; Scott JP; Roden AC J Heart Lung Transplant; 2020 Feb; 39(2):165-175. PubMed ID: 31870771 [TBL] [Abstract][Full Text] [Related]
34. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484 [TBL] [Abstract][Full Text] [Related]
35. Pathologic diagnosis of antibody-mediated rejection in endomyocardial biopsy after heart transplantation based on renewed International Society for Heart and Lung Transplantation criteria. Szymańska S; Grajkowska W; Pronicki M Pol J Pathol; 2014 Oct; 65(3):176-81. PubMed ID: 25372414 [TBL] [Abstract][Full Text] [Related]
36. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant. Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C Front Immunol; 2019; 10():1208. PubMed ID: 31249568 [TBL] [Abstract][Full Text] [Related]
37. Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection. Koenig A; Mezaache S; Callemeyn J; Barba T; Mathias V; Sicard A; Charreau B; Rabeyrin M; Dijoud F; Picard C; Meas-Yedid V; Olivo-Marin JC; Morelon E; Naesens M; Dubois V; Thaunat O J Am Soc Nephrol; 2021 Feb; 32(2):479-494. PubMed ID: 33239394 [TBL] [Abstract][Full Text] [Related]
38. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Sellarés J; Reeve J; Loupy A; Mengel M; Sis B; Skene A; de Freitas DG; Kreepala C; Hidalgo LG; Famulski KS; Halloran PF Am J Transplant; 2013 Apr; 13(4):971-983. PubMed ID: 23414212 [TBL] [Abstract][Full Text] [Related]
39. The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Venner JM; Hidalgo LG; Famulski KS; Chang J; Halloran PF Am J Transplant; 2015 May; 15(5):1336-48. PubMed ID: 25787894 [TBL] [Abstract][Full Text] [Related]
40. Exploring the cardiac response to injury in heart transplant biopsies. Halloran PF; Reeve J; Aliabadi AZ; Cadeiras M; Crespo-Leiro MG; Deng M; Depasquale EC; Goekler J; Jouven X; Kim DH; Kobashigawa J; Loupy A; Macdonald P; Potena L; Zuckermann A; Parkes MD JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]